Find clinical trials for Endometrial Cancer in New York, NY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Endometrial Cancer trials near New York, NY, USA:
This research study is studying a drug combination as a possible treatment for endometrial cancer.The drugs involved in this study ...
Phase 2
Lake Success, New York, United States and 2 other locations
A Phase 2 Multi-center Open-label Trial of nab-Sirolimus in Combination with Letrozole in Advanced or Recurrent Endometrioid Endometrial Cancer...
Phase 2
New York, New York, United States and 7 other locations
and Femara (letrozole) can help to control recurrent or progressive endometrial cancer. The safety of this drug combination will al...
Phase 2
Morristown, New Jersey, United States and 1 other location
This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial...
Phase 2
New Brunswick, New Jersey, United States and 2 other locations
This is a Phase IB/II multi-cohort study designed to evaluate the efficacy and safety of targeted agents with or without cancer immune check ...
Phase 1, Phase 2
New York, New York, United States and 19 other locations
The primary objectives of this study are to compare sacituzumab tirumotecan to Treatment of Physician's Choice (TPC) with respect to progression-free...
Phase 3
New York, New York, United States and 71 other locations
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
New York, New York, United States and 28 other locations
study is designed to evaluate the efficacy, safety, and pharmacokinetics of giredestrant monotherapy in participants with Grade 1 endometrioid endometrial...
Phase 2
Englewood, New Jersey, United States and 18 other locations
(ON 123300) in combination with the standard daily dose (2.5mg) of letrozole in patients with Recurrent Metastatic Low-grade Endometrioid Endometrial...
Phase 1, Phase 2
New York, New York, United States and 7 other locations
This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial c...
Phase 2
New York, New York, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal